Authors

• Olivia Hapanowicz
• Deborah B. Doroshow (ORCID: https://orcid.org/0000-0002-2221-9818)
• Mary Beth Beasley (ORCID: https://orcid.org/0000-0003-2340-1897)
• Nicholas Venturini (ORCID: https://orcid.org/0000-0002-3769-5956)
• Brian Housman
• David F. Yankelevitz (ORCID: https://orcid.org/0000-0001-7364-4294)
• Natalie Lucas
• Udit Chaddha (ORCID: https://orcid.org/0000-0003-0067-1616)
• Timothy J. Harkin (ORCID: https://orcid.org/0000-0001-9139-1497)
• Kathy Wu
• Nicholas Rohs
• Jan Wilk
• Thomas U. Marron (ORCID: https://orcid.org/0000-0001-5903-8191)
• Ardeshir Hakami-Kermani
• Lisa Fitzgerald (ORCID: https://orcid.org/0000-0003-0323-0023)
• Miriam Mérad (ORCID: https://orcid.org/0000-0002-4481-7827)
• Daniel Nicastri
• Matthew Park
• Fionnuala Crowley (ORCID: https://orcid.org/0000-0001-9101-3912)
• Andrew Kaufman

Institutions

• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

Journal of Clinical Oncology

Published

2025-05-28

DOI

https://doi.org/10.1200/jco.2025.43.16_suppl.tps2696

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

0.00